Citadel Advisors’s Harte-Hanks HHS Stock Holding History

Citadel Advisors’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,880	Closed	-$30K	–	7424
2016 Q2	$30K	Buy	+1,880	New	+$33.2K	﹤0.01%	6521
2016 Q1	–	Sell	-200	Closed	-$6K	–	7256
2015 Q4	$6K	Sell	200 -1,340	-87%	-$50.2K	﹤0.01%	8406
2015 Q3	$54K	Buy	1,540 +1,120	+267%	+$50.5K	﹤0.01%	7525
2015 Q2	$25K	Buy	420 +320	+320%	+$21.5K	﹤0.01%	8057
2015 Q1	$8K	Buy	+100	New	+$7.73K	﹤0.01%	8239
2014 Q3	–	Sell	-60	Closed	-$4K	–	8227
2014 Q2	$4K	Buy	+60	New	+$4.63K	﹤0.01%	7756
2013 Q4	–	Sell	-150	Closed	-$13K	–	7068
2013 Q3	$13K	Buy	+150	New	+$13.7K	﹤0.01%	6392

Other funds holding HHS

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

WCM

Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's HHS Position: Q3 2024 in Review

Citadel Advisors sold out of Harte-Hanks (HHS) in Q3 2024, closing a stake of 28,948 shares — an estimated $235K sold.

Citadel Advisors first reported a position in HHS in Q2 2013 and held it in 20 quarters. The position peaked at $2.42M in Q2 2013. 25 funds tracked by Wall St. Rank hold HHS as of Q3 2024.

Citadel Advisors reported no remaining Harte-Hanks position as of Q3 2024 after selling out during the quarter.
Citadel Advisors sold 28,948 Harte-Hanks shares in Q3 2024, an estimated $235K.
Citadel Advisors first reported a position in Harte-Hanks in Q2 2013 and held it in 20 quarters.
Citadel Advisors's Harte-Hanks position peaked at $2.42M in Q2 2013.
25 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.